Survival after resection of appendiceal carcinoma by hemicolectomy and less radical than hemicolectomy: a population-based propensity score matched analysis.

医学 倾向得分匹配 半结肠切除术 比例危险模型 淋巴结切除术 人口 内科学 外科 生存分析 胃肠病学 泌尿科
作者
Hanna Elias,Christian Galata,Rene Warschkow,Bruno M. Schmied,Thomas Steffen,Stefan Post,Lukas Marti
出处
期刊:Colorectal Disease [Wiley]
卷期号:19 (10): 895-906 被引量:4
标识
DOI:10.1111/codi.13746
摘要

Background The operative treatment for non-metastatic appendiceal carcinoma is controversial despite the recommendation of right hemicolectomy by many researchers. The aim of this population-based study was to compare outcomes after right hemicolectomy (RH) and less radical resection than right hemicolectomy (LRH). Methods A total of 1144 patients who underwent resection with additional lymphadenectomy of stage I-III appendiceal carcinoma from 2004 to 2012 was identified in the Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) and cancer-specific survival (CSS) after RH and LRH were assessed by unadjusted and risk-adjusted Cox regression analysis and by propensity score matched analysis. Results A total of 855 (74.7%) patients underwent RH, and 289 (25.3%) underwent LRH. In an unadjusted analysis, survival after LRH and RH did not differ in OS (HR=0.95, 95%CI: 0.71−1.27, P=0.707) and CSS (HR=0.95, 95%CI: 0.68−1.32, P=0.762). The 5-year OS and CSS in patients who underwent RH were 71.6% (95%CI: 67.8-75.6%) and 76.4% (95%CI: 72.8-80.3%) compared with 73.8% (95%CI: 67.9-80.2%) and 78.7% (95%CI: 73.2-84.7%) in patients with LRH, respectively. No relevant difference in survival between LRH and RH could be observed in a multivariable analysis (OS: HR=0.90, 95%CI: 0.65-1.25, P=0.493 and CSS: HR=0.87, 95%CI: 0.60-1.26, P=0.420) and after propensity score-adjusted analysis (OS: HR=0.87, 95%CI: 0.62−1.22, P=0.442 and CSS: HR=0.97, 95%CI: 0.67−1.40, P=0.883). Conclusions In this retrospective analysis, survival after RH for non-metastatic appendiceal carcinoma was not statistically significantly superior to LRH. Hence, LRH with lymphadenectomy might be sufficient for treatment of non-metastatic appendiceal carcinoma. This article is protected by copyright. All rights reserved.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
畅快妙竹完成签到,获得积分10
刚刚
1717完成签到,获得积分10
刚刚
nxdsk发布了新的文献求助10
1秒前
123jopop完成签到,获得积分10
1秒前
1秒前
田様应助颜九伊采纳,获得10
1秒前
优美从菡完成签到,获得积分10
1秒前
2秒前
2秒前
张鹏举完成签到 ,获得积分10
2秒前
3秒前
深情安青应助蜗牛采纳,获得10
3秒前
4秒前
李慧敏完成签到,获得积分10
4秒前
Joye发布了新的文献求助20
4秒前
pooolw完成签到,获得积分10
4秒前
羊羊发布了新的文献求助10
5秒前
斯文砖家完成签到 ,获得积分10
5秒前
小马发布了新的文献求助10
5秒前
周老八发布了新的文献求助10
5秒前
宁祚完成签到,获得积分10
5秒前
ll发布了新的文献求助10
5秒前
6秒前
6秒前
6秒前
6秒前
水东流发布了新的文献求助10
7秒前
7秒前
7秒前
7秒前
伯赏松思完成签到,获得积分10
8秒前
8秒前
ZGH发布了新的文献求助10
9秒前
arzw完成签到,获得积分10
9秒前
善学以致用应助zengxi246采纳,获得10
10秒前
10秒前
nxdsk完成签到,获得积分10
11秒前
11秒前
JAYGOD发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Digital Twins of Advanced Materials Processing 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6040568
求助须知:如何正确求助?哪些是违规求助? 7777009
关于积分的说明 16231248
捐赠科研通 5186669
什么是DOI,文献DOI怎么找? 2775483
邀请新用户注册赠送积分活动 1758574
关于科研通互助平台的介绍 1642194